“Rising Adoption of Epigenetic Biomarkers & Personalized Medicine”
- One prominent trend in the epigenetics market is the increasing adoption of epigenetic biomarkers in disease diagnosis, prognosis, and treatment monitoring, especially in oncology and neurology
- This trend is driven by the growing demand for personalized medicine, as epigenetic profiling enables tailored therapeutic strategies based on an individual’s gene expression patterns
- For instance, the use of DNA methylation markers in cancer screening (for instance, colorectal or lung cancer) allows for earlier detection and more accurate risk assessment, improving treatment outcomes
- The integration of epigenetic data with next-generation sequencing and AI-powered analytics is accelerating biomarker discovery and precision diagnostics, fueling market growth and innovation
